| |
Watson Bio mainly produces TAXOL, 80% of which is sold to overseas cancer-resistant medicine (tablets, injections) manufacturers in the U.S. and Europe, and some to domestic large-scale medicine manufacturers or corporations such as Taiji. 60% of Watson Bio"s export businesses are conducted by some qualified import and export companies, and the rest products are either directly exported to foreign markets or directly distributed to domestic medicine manufacturers. In connection with the company’s other products and the equipment as well as the market characteristic, other product sales take direct sales pattern primarily, by sells goods on the consignment pattern auxiliary. In the year 2002 other products by direct sales account for 87.8% of the total sales volume, goods sell on the consignment way accounts for 12.2% of the total sales volume. In the year 2003 direct sales product accounts for 90.8% of the total sales, the proxy pattern sales product accounts for 9.1% of the total sales. By expert Promotes the marketing strategy primarily to develop the service, at present moves smoothly, the influence enhance year-by-year in the industry, achievement also have fast growth year by year.
|
|
